https://www.selleckchem.com/pr....oducts/Gefitinib.htm
To determine the percentages of (CD19+CD24+CD38+, CD19+CD24+CD27+, CD19+IL-10+)-Breg cells, IL-17 single and IL-17+/IFN-γ double producers T cells and IFN-γ+T cells, in normal-glycemic individuals, prediabetes and T2DM patients, and to analyze the association of Breg cells with metabolic parameters of T2DM. percentages of Breg cells, IL-17+and IL-17+IFN-γ+T cells, IFN-γ+T cells and IL-10 were determined by flow cytometry. IL-6 levels were evaluated by ELISA assay. increased IL-6 levels, IL-17+and IL-17+IFN-γ+T cells and a diminution o
Like
Comment
Share
